972
Views
94
CrossRef citations to date
0
Altmetric
Review

Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology

, &
Pages 447-454 | Published online: 21 Sep 2016

References

  • FashnerJBellALHerpes zoster and postherpetic neuralgia: prevention and managementAm Fam Physician201183121432143721671543
  • GhariboCKimCNeuropathic pain of postherpetic neuralgiaPain Med News201198492
  • TontodonatiMUrsiniTPolilliEVadiniFDi MasiFVolponeDParrutiGPost-herpetic neuralgiaInt J Gen Med2012586187123109810
  • GildenDCohrsRJMahalingamRNagelMANeurological disease produced by varicella zoster virus reactivation without rashCurr Top Microbiol Immunol201034224325320186614
  • NagelMAGildenDComplications of varicella zoster virus reactivationCurr Treat Options Neurol201315443945323794213
  • KilgorePEKruszon-MoranDSewardJFVaricella in Americans from NHANES III: implications for control through routine immunizationJ Med Virol200370Suppl 1S111S11812627498
  • HarpazROrtega-SanchezIRSewardJFAdvisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep200857RR-513018528318
  • KlompasMKulldorffMVilkYBialekSRHarpazRHerpes zoster and postherpetic neuralgia surveillance using structured electronic dataMayo Clin Proc201186121146115321997577
  • NagasakoEMJohnsonRWGriffinDRDworkinRHRash severity in herpes zoster: correlates and relationship to postherpetic neuralgiaJ Am Acad Dermatol200246683483912063479
  • ForbesHJThomasSLSmeethLClaytonTFarmerRBhaskaranKLanganSMA systematic review and meta-analysis of risk factors for postherpetic neuralgiaPain20161571305426218719
  • WoolfCJMannionRJNeuropathic pain: aetiology, symptoms, mechanisms, and managementLancet199935391681959196410371588
  • DroletMBrissonMSchmaderKEThe impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyCMAJ2010182161731173620921251
  • HaanpaaMAttalNBackonjaMNeuPSIG guidelines on neuropathic pain assessmentPain20111521142720851519
  • NalamachuSMorley-ForsterPDiagnosing and managing postherpetic neuralgiaDrugs Aging2012291186386923038608
  • BackonjaMMAttalNBaronRValue of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensusPain201315491807181923742795
  • ArgoffCEReview of current guidelines on the care of postherpetic neuralgiaPostgrad Med2011123513414221904096
  • FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review, meta-analysis and updated NeuPSIG recommendationsLancet Neurol201514216217325575710
  • WelsbyPDChickenpox, chickenpox vaccination, and shinglesPostgrad Med J20068296735135216679476
  • Zostavax® (zoster vaccine live) [package insert]Whitehouse Station, NJMerck & Co Inc2014
  • OxmanMNZoster vaccine: current status and future prospectsClin Infect Dis201051219721320550454
  • GagliardiAMGomes SilvaBNTorloniMRSoaresBGVaccines for preventing herpes zoster in older adults [review]Cochrane Database Syst Rev201210CD00885823076951
  • WilliamsWWLuPJO’HalloranACenters for Disease Control and Prevention (CDC)Surveillance of Vaccination Coverage Among Adult Populations – United States, 2014MMWR Surveill Summ201665113626844596
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
  • Centre for Clinical Practice at NICE (UK) – National Institute for Health and Care Excellence: Clinical GuidelinesNeuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist SettingsLondonNational Institute for Health and Care Excellence, UK2013
  • HinesLEMurphyJEPotentially harmful drug-drug interactions in the elderly: a reviewAm J Geriatr Pharmacother20119636437722078863
  • RoutledgePAO’MahonyMSWoodhouseKWAdverse drug reactions in elderly patientsBr J Clin Pharmacol200457212112614748810
  • MassengillJSKittredgeJLPractical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care providerJ Pain Res2014712513224648752
  • SelphSCarsonSFuRThakurtaSLowAMcDonaghMDrug Class Review: Neuropathic Pain: Final Update 1 ReportPortland (OR)Oregon Health & Science University2011
  • DworkinRHO’ConnorABAudetteJRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateMayo Clin Proc2010853 SupplS31420194146
  • CampanelliCMAmerican Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adultsJ Am Geriatr Soc201260461663122376048
  • DolphinACCalcium channel alpha2-delta subunits in epilepsy and as targets for antiepileptic drugsNoebelsJLAvoliMRogawskiMAOlsenRWDelgado-EscuetaAVJasper’s Basic Mechanisms of the EpilepsiesBethesda, MDNational Center for Biotechnology Information (US)2012
  • IrvingGOnce-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for cliniciansTher Adv Chronic Dis20123521121823342236
  • Neurontin® (gabapentin) [package insert]New York, NYParke-Davis Division of Pfizer, Inc2015
  • JohnsonPBeckerLHalpernRSweeneyMReal-world treatment of post-herpetic neuralgia with gabapentin or pregabalinClin Drug Investig20133313544
  • Gralise® (gabapentin) [package insert]Newark, CADepomed, Inc2012
  • ChenCHanCHSweeneyMCowlesVEPharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgiaJ Pharm Sci201310241155116423381946
  • Horizant® (gabapentin enacarbil) [package insert]Santa Clara, CAXenoPort, Inc2013
  • KumeAGabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?Neuropsychiatr Dis Treat20141024926224523590
  • ThomasBMFarquhar-SmithPGabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adultsTher Clin Risk Manag2013946947524353426
  • RauckRLIrvingGAWallaceMSVanhoveGFSweeneyMOnce-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studiesJ Pain Symptom Manage201346221922823149085
  • Lyrica® (pregabalin) [package insert]New York, NYParke-Davis Division of Pfizer Inc2013
  • CappuzzoKATreatment of postherpetic neuralgia: focus on pregabalinClin Interv Aging20094172319503762
  • IfukuMIsekiMHidakaIMoritaYKomatusSInadaEReplacement of gabapentin with pregabalin in postherpetic neuralgia therapyPain Med20111271112111621692969
  • PatornoEBohnRLWahlPMAvornJPatrickARLiuJSchneeweissSAnticonvulsant medications and the risk of suicide, attempted suicide, or violent deathJAMA2010303141401140920388896
  • DerrySSven-RiceAColePTanTMooreRATopical capsaicin (high concentration) for chronic neuropathic pain in adults [review]Cochrane Database Syst Rev20132CD00739323450576
  • Qutenza® (capsaicin) [package insert]Ardsley, NYAcorda Therapeutics, Inc2013
  • DerrySWiffenPJMooreRAQuinlanJTopical lidocaine for neuropathic pain in adults [review]Cochrane Database Syst Rev20147CD01095825058164
  • DubinskyRMKabbaniHEl-ChamiZBoutwellCAliHQuality Standards Subcommittee of the American Academy of NeurologyPractice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200463695996515452284
  • CasaleRDi MatteoMMinellaCEFanelliGAllegriMReduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case seriesJ Pain Res2014735335725018649
  • BajwaZHOrtegaEPostherpetic neuralgia. UptoDate 2016 Available from: http://www.uptodate.com/contents/postherpetic-neuralgiaAccessed May 25, 2016
  • MannENeuropathic pain: could nurses become more involved?Br J Nurs200817191208121318974688
  • DerrySWiffenPJAldingtonDMooreRANortriptyline for neuropathic pain in adults [review]Cochrane Database Syst Rev20151CD01120925569864
  • Lidoderm® (lidocaine patch 5%) [package insert]Malvern, PAEndo Pharmaceuticals, Inc2015
  • Oxycontin® (oxycodone HCl) [package insert]Stamford, CTPurdue Pharma L.P2015
  • Roxicodone® (oxycodone hydrochloride tablets USP) [package insert]Hazelwood, MOMallinckrodt, Inc2014
  • Morphine Oral Solution (morphine sulfate) [package insert]Hazelwoood, MOMallinckrodt, Inc2014
  • MS CONTIN® (morphine sulfate extended-release tablets) [package insert]Hazelwood, MOMallinckrodt, Inc2014
  • ULTRAM® ER (tramadol) [package insert]Titusville, NJJanssen Pharmaceuticals, Inc2014
  • Qutenza® (capsaicin) 8% patch [package insert]Ardsley, NYAcorda Therapeutics, Inc2013